2023 - Research.com Medicine in Australia Leader Award
Henry Krum focuses on Internal medicine, Heart failure, Cardiology, Surgery and Blood pressure. Henry Krum combines subjects such as Placebo and Endocrinology with his study of Internal medicine. Henry Krum interconnects Heart disease, Myocardial infarction and Intensive care medicine in the investigation of issues within Heart failure.
His work deals with themes such as Ambulatory, Adverse effect and Heart rate, which intersect with Cardiology. His Surgery research includes themes of Anemia and Diuretic. The study incorporates disciplines such as Anesthesia, Denervation and Renal function in addition to Blood pressure.
Henry Krum mainly investigates Internal medicine, Heart failure, Cardiology, Endocrinology and Intensive care medicine. His Internal medicine research incorporates themes from Placebo and Surgery. He works mostly in the field of Heart failure, limiting it down to topics relating to Clinical trial and, in certain cases, Randomized controlled trial.
His study focuses on the intersection of Cardiology and fields such as Renal function with connections in the field of Kidney disease and Kidney. Henry Krum has included themes like Fibrosis and Urotensin-II in his Endocrinology study. His Blood pressure study combines topics in areas such as Anesthesia and Denervation.
His primary scientific interests are in Internal medicine, Heart failure, Cardiology, Ejection fraction and Intensive care medicine. Henry Krum studies Blood pressure, a branch of Internal medicine. His Blood pressure research is multidisciplinary, incorporating perspectives in Renal artery, Kidney and Denervation.
The Heart failure study combines topics in areas such as Clinical trial and Hazard ratio. His Cardiology research includes elements of Sympathetic nervous system and Renal function. Henry Krum works mostly in the field of Intensive care medicine, limiting it down to topics relating to Kidney disease and, in certain cases, Disease, as a part of the same area of interest.
His scientific interests lie mostly in Internal medicine, Heart failure, Cardiology, Randomized controlled trial and Ejection fraction. His work carried out in the field of Internal medicine brings together such families of science as Placebo and Surgery. Henry Krum combines subjects such as Clinical endpoint, Clinical trial, Myocardial infarction and Intensive care medicine with his study of Heart failure.
His research in Cardiology intersects with topics in Endocrinology and Renal function. His study explores the link between Randomized controlled trial and topics such as Blood pressure that cross with problems in Denervation and Confounding. His work in the fields of Ejection fraction, such as Stroke volume, overlaps with other areas such as Ethnic group.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Effect of carvedilol on survival in severe chronic heart failure.
Milton Packer;Andrew Js Coats;Michael B Fowler;Hugo A Katus.
The New England Journal of Medicine (2001)
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): A randomised controlled trial
Murray D. Esler;Henry Krum;Paul A. Sobotka;Markus P. Schlaich.
The Lancet (2010)
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
Faiez Zannad;John J. V. McMurray;Henry Krum;Dirk J. van Veldhuisen.
The New England Journal of Medicine (2011)
Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study
Henry Krum;Markus Schlaich;Robert Whitbourn;Paul Sobotka.
The Lancet (2009)
Targeted Anticytokine Therapy in Patients with Chronic Heart Failure: Results of the Randomized Etanercept Worldwide Evaluation (RENEWAL)
Douglas L. Mann;John J.V. McMurray;Milton Packer;Karl Swedberg.
Effect of nesiritide in patients with acute decompensated heart failure.
C. M. O'Connor;R. C. Starling;A. F. Hernandez;P. W. Armstrong.
The New England Journal of Medicine (2011)
Renal Sympathetic-Nerve Ablation for Uncontrolled Hypertension
Markus P. Schlaich;Paul A. Sobotka;Henry Krum;Elisabeth Lambert.
The New England Journal of Medicine (2009)
Aliskiren, ALTITUDE, and the implications for ATMOSPHERE
John J.V. McMurray;William T. Abraham;Kenneth Dickstein;Lars Køber.
European Journal of Heart Failure (2012)
Heart failure: preventing disease and death worldwide.
Piotr P. Ponikowski;Stefan D. Anker;Khalid F. AlHabib;Martin R. Cowie.
Esc Heart Failure (2014)
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
Paul M Ridker;Jean G MacFadyen;Tom Thuren;Brendan M Everett.
The Lancet (2017)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: